Clinical Trial Update: Observational Study Providing 12 Months of Safety Follow-Up From First Exposure to HP802-247

View source ↗

Summary

Observational safety follow-up study providing 12 months of safety data after first exposure to HP802-247 in patients with venous leg ulcers; study status is co…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Venous Leg Ulcer

Drugs mentioned

• hp802-247

Snippet

Sponsor: Healthpoint | Conditions: Venous Leg Ulcer (VLU) | Status: COMPLETED